Tiziana Life Sciences Ltd. (TLSA), a biotech firm focused on immunomodulation therapies, announced that its Executive Chairman and Founder, Gabriele Cerrone, has acquired 15,000 additional common shares at $1.55 each.
This purchase increases his total holdings to 43,252,143 shares, representing 37.02% of the company's issued share capital.
TLSA is currently trading at $1.5099 or 3.8280% lower on the Nasdaq Capital Market.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.